Biobanking in Finland: a success story
Finland’s unique biobanking landscape makes it an ideal environment for pharmaceutical and health research, as told to Health Europa.
Finland may be a small country,...
Wellcome Trust and Gates Foundation announce backing for EU’s Plan-S
Plan-S is the controversial initiative demanding immediate open access to scientific literature, and now two of the biggest medical research funders are in support...
From highly priced medicines to Medicines That Matter
Highly priced medicines represent a significant public health challenge. Global health advocate Ella Weggen shares how Wemos is responding through its dedicated project Medicines...
Can biocompatible materials make broken fillings a thing of the past?
New dental reconstruction material developed in Sweden using biocompatible materials offers unprecedented improvements over existing acrylate-based fillers.
Individuals may no longer have to worry about...
Enzyme function affected by changes in external surface
Research shows changes to enzyme surfaces affects the enzyme function, this being the substrate specificity by modifying how densely it is packed inside.
These findings...
Bar-Ilan University: Nano-Institute at the cutting edge of medical research
Offering a glimpse into breakthrough research, Health Europa explores with Bar-Ilan University, their Nanotechnology Institute that’s advancing medicine.
The Institute for Nanotechnology and Advanced Materials...
BioBlocks, Inc.: Transforming the process of lead discovery
BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches.
BioBlocks is a medicinal...
Artificial Intelligence centres of excellence to be launched across the UK
Five new Artificial Intelligence centres are to be established in the UK to help hospitals make scans and biopsy images digital in a bid...
NHS to be short of 51,000 nurses by the end of the Brexit transition...
New report reveals the NHS could be short of 51,000 nurses, enough to staff 45 hospitals, by the end of the Brexit transition period.
The...
The importance of having strong research infrastructures in healthcare
Health Europa highlights the importance of research infrastructures in the health and care landscape in Europe.
Future developments in healthcare and technology innovation rely on...
Open Targets – transforming drug discovery
Health Europa talks with Open Targets who discuss how the platform works to systematically identify and prioritise drug discovery to develop safe and effective...
Nanobots in medicine: the key to fighting chronic diseases with nanomedicine
The emerging technology of nanobots in medicine offers better chances of exploiting nanomedicine to fight chronic diseases such as cancer.
Nanomedicine is a domain of...
Cocaine contaminant, levamisole, may cause brain damage
Individuals who regularly take the cocaine contaminant, levamisole, demonstrate impaired cognitive performance & a thinned prefrontal cortex.
Recent findings from the University of Zurich, Switzerland, indicate...
Measuring the length of a physician’s arms – or ensuring the competencies of healthcare...
INNO-X Healthcare discuss their efforts to ensure the healthcare staff of the future are equipped with the skills and competencies they need to best...
Dementia in Europe: a public health priority?
Following the European Commission’s decision to disband the Expert Group on Dementia, we speak to Alzheimer Europe to hear their case for a co-ordinated...
Are Mycoplasma bacteria sneaking past our line of defence?
New research reveals that Mycoplasma bacteria make DNA in a unique way that may protect them from our immune response.
Researchers from Stockholm University, Sweden,...
Mucopolysaccharide storage diseases and puberty and adolescence
The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...
Novel antibacterial compounds created to battle antibiotic resistance development
Researchers from the University of Eastern Finland have created novel antibacterial compounds to combat antibiotic resistance development.
Focusing on the role of LsrK kinase, the...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance
Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring.
The costly, time-consuming and error-prone...
Neurosteer: introducing a novel brain activity monitor
Neurosteer has developed a three-electrode neurological monitor that provides multiple brain activity biomarkers.
Neurosteer has the mission to improve the quality of brain disorder care...